Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 29
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Vivo Bio Tech Ltd. engages in the provision of drug development and discovery services. It offers services in the areas of vivo and vitro toxicity studies, Pharmacological investigations, Pharmacokinetic and toxicokinetic studies, Genotoxicity screening and Analytical services. The firm operates through Bio Agriculture and Industrial segments. The company was founded by Vish Kompella on February...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD
Data is available to registered users only
Buy
Sell